A Food and Drug Administration panel of advisors is recommending approval of the first imaging test to help screen for Alzheimer’s disease. The news is especially exciting for Rush University researchers who participated in the study of the new imaging dye. The imaging test involves an injection of Amyvid, a chemical dye that makes brain plaque visible […]![]()
